Search research articles
Contact Us
Filters
Showing results (121-130 of 127) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 127 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group
G Cocconi, D Cunningham, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2005
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF
J Andersson, L Larsson, S Klaar, et al.
Cancer Research
|
January 1, 1992
Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction
T Horikoshi, K D Danenberg, T H Stadlbauer, et al.
Elife
|
May 12, 2021
Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca<sup>2+</sup> and phosphorylation
Daniel K Weber, U Venkateswara Reddy, Songlin Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group
B Glimelius, A Jakobsen, W Graf, et al.
The Pharmacogenomics Journal
|
August 12, 2015
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin
J B Kjersem, M Thomsen, T Guren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia
U Tidefelt, J Liliemark, A Gruber, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 127) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 127 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group
G Cocconi, D Cunningham, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2005
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF
J Andersson, L Larsson, S Klaar, et al.
Cancer Research
|
January 1, 1992
Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction
T Horikoshi, K D Danenberg, T H Stadlbauer, et al.
Elife
|
May 12, 2021
Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca<sup>2+</sup> and phosphorylation
Daniel K Weber, U Venkateswara Reddy, Songlin Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group
B Glimelius, A Jakobsen, W Graf, et al.
The Pharmacogenomics Journal
|
August 12, 2015
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin
J B Kjersem, M Thomsen, T Guren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia
U Tidefelt, J Liliemark, A Gruber, et al.
Page
of 13